Ulcerative Colitis Market Overview
As per the reports published by Market Research Future (MRFR), the worldwide ulcerative colitis market has been recorded as a growing market. The market can be estimated to generate remarkable worth in the coming future. Ulcerative colitis is a category of inflammatory bowel disease (IBD) that mostly impacts the lower region of the body such as the rectum and sigmoid colon. Diarrhea, bleeding from the rectum, belly pain, and cramps are some of the common signs of ulcerative colitis. As per the studies conducted by the Centers for Disease Control, global prevalence of ulcerative colitis has been recorded to be witnessing 0.5 to 24.5 cases per 100,000 people every year. Chances of recurrence of the ailment’s signs is also high. The Colitis Foundation of America stated that almost 30% of people on remission are likely to suffer from the ailment seethe in the future, right after the cure and remission.
Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/2354
Another study published by the American Family Physician stated that ulcerative colitis impacts between 250,000 and 500,000 individuals in the United States, with a yearly prevalence of 2 to 7 per 100,000 people. Ulcerative colitis primarily impacts the large intestine. Additionally, it might also affect the joints, skin, and eyes. The colon gets inflamed when affected by ulcerative colitis. In extreme instances, ulcers are formed on the edges of the colon. The ulcers often produce mucus, pus, and in severe cases it might bleed. The rectum being the conclusion of the colon gets always involved in ulcerative colitis. The ailment is called ulcerative proctitis, if the inflammation has only taken place in the rectum. However, the inflammation is likely to affect the upper areas of the colon. Pancolitis or universal colitis is the condition when the entire colon is affected. The precise cause that triggers ulcerative colitis has not been found yet. Doctors used to assume stress and irregular diet are the two major reasons causing ulcerative colitis. But of late, doctors have concluded that these factors are likely to worsen the ailment but they can’t cause it at the first place. Key factors propelling the market growth majorly includes the rising instances of ulcerative colitis, improved cure of inflammatory bowel ailments, arrival of enhanced drugs, creating patient pool with unmet requirements, novel drugs entering the market, surging global incidence & prevalence rate, soaring outlays towards research in small molecules, and remarkable investments in the entire R&D programs. Blockbuster drugs are gradually losing patent protection. Besides, they are surging the propensity for generic drugs which can limit the market growth. The lack of personalized therapy, medication, and curative therapy are the major opportunities for the prosperity of the market.
Ulcerative Colitis Market Segmentation
Global ulcerative colitis market has been segmented based on medication and type. Based on medication the market has been segmented into steroids, 5-aminosalicylates, immunomodulators, biologics, and purine analogs. Biologics are estimated to hold the largest market share. Steroids drugs are likely to expand at the highest CAGR over the forecast period. Based on types, the market has been segmented as proctosigmoiditis, ulcerative proctitis, pancolitis or universal colitis, fulminant colitis, and left-sided colitis. Ulcerative proctitis has been estimated to hold the largest market share over the forecast period.
Ulcerative Colitis Market Regional Analysis
In 2016, North America was projected to account for the largest share of the worldwide ulcerative colitis market followed by Europe. The region is likely to continue dominating the pack over the forecast period. In the Asia-Pacific region, China leads the ulcerative colitis market. Improvement of healthcare facilities coupled with economic development are accelerating the development of the market.
Ulcerative Colitis Market Key Players
Global ulcerative colitis market has been dominated by key players such as AbbVie Inc., Allergan, Inc., UCB S.A., Pfizer Inc., Takeda Pharmaceutical Company Limited, Ferring B.V., Bayer AG, Perrigo Company plc, Janssen Biotech, Merck, and Johnson & Johnson Services, Inc.
Table Of Contents
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5 GLOBAL ULCERATIVE COLITIS MARKET, BY TYPE
…Continued
Get access to full summary @ https://www.marketresearchfuture.com/reports/ulcerative-colitis-market-2354
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
